spironolactone has been researched along with diethylnitrosamine in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kidoguchi, S; Kitada, K; Kittikulsuth, W; Kobara, H; Masaki, T; Nakajima, K; Nakano, D; Nishiyama, A; Ohsaki, H; Takahashi, K; Titze, J; Yokoo, T | 1 |
1 other study(ies) available for spironolactone and diethylnitrosamine
| Article | Year |
|---|---|
Hepatocellular carcinoma induces body mass loss in parallel with osmolyte and water retention in rats.
Topics: Aldosterone; Animals; Carcinoma, Hepatocellular; Diethylnitrosamine; Liver Neoplasms, Experimental; Male; Mineralocorticoid Receptor Antagonists; Neoplasm Proteins; Rats; Rats, Inbred WKY; Receptors, Mineralocorticoid; Spironolactone; Water-Electrolyte Balance; Weight Loss | 2022 |